Isosceles Pharmaceuticals, Inc. — Form C (Regulation Crowdfunding)

Isosceles Pharmaceuticals, Inc. of Wilmington, NC filed a Form C (Regulation Crowdfunding) with the SEC on 2022-10-03. Target raise $20K, up to $5.0M. Offered through Equifund Crowd Funding Portal Inc..

Offering

• Filed: 2022-10-03
• Form: C
• Accession: 0001213900-22-061146
• Target amount: $20K
• Maximum amount: $5.0M
• Security type: Common Stock
• Securities offered: 9,756
• Price: $2.0500
• Deadline: 2023-10-02
• Funding portal / intermediary: Equifund Crowd Funding Portal Inc.
• Intermediary file number: 007-00115
• Intermediary CRD: 288900

Issuer

• CIK: 0001949237
• Website: www.isoscelespharma.com
• Legal status: Corporation
• Organized in: NV
• Incorporated: 2019-04-12
• Address: 1213 Culbreth Dr. Suite 359, Wilmington, NC, 28405
• Employees: 10

Financials (as filed)

• Total assets (most recent): $213K
• Cash (most recent): $213K
• Net income (most recent): $880K
• Net income (prior): $892K
• Long-term debt: $120K

People (1)

More

• CIK 1949237 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search